Results 191 to 200 of about 142,445 (236)
Some of the next articles are maybe not open access.
Immunosuppression in gastroenterology and hepatology
Best Practice & Research Clinical Gastroenterology, 2021In recent years, the clinician has a more diverse approach to immunosuppression. Now, for many conditions, such as solid organ transplantation or treatment of some autoimmune diseases, the consequences of immunosuppression becomes a greater risk than organ failure from immune-mediated disease.
openaire +2 more sources
Update in Gastroenterology and Hepatology
Annals of Internal Medicine, 2004This Update summarizes 11 studies published in 2009 relevant to the practice of gastroenterology and hepatology.
Norton J, Greenberger, Prateek, Sharma
openaire +4 more sources
Gastroenterology and Hepatology
JAMA: The Journal of the American Medical Association, 1991Pharmacotherapy for gastroesophageal reflux disease is needed when simple measures fail. Antacids, H 2 blockers, sucralfate, and (occasionally) metaclopramide may be effective. Treatment failures may respond to omeprazole (Prilosec), a recently released agent that blocks hydrogen ion secretion by the gastric parietal cells.
openaire +2 more sources
Gastroenterology and Hepatology
JAMA: The Journal of the American Medical Association, 1995Development of colon cancer is now believed to result from a series of inherited or acquired mutations in DNA. Convincing evidence that colonoscopic polypectomy prevents colorectal cancer is now available. A consensus panel recommended that all patients with duodenal and gastric ulcers who are infected with H pylori on first presentation be treated ...
openaire +2 more sources
Gastroenterology and hepatology.
JAMA, 1997Diseases of the gastrointestinal (GI) tract may involve a myraid of organ systems including the luminal gut, the liver, biliary tract, and pancreas. A basic understanding of GI illnesses and their presenting signs and symptoms is essential for the primary care physician.
W L, Peterson, W M, Lee
+5 more sources
Gastroenterology and hepatology
2016Chapter 8 discusses gastroenterology and hepatology as it relates to acute medicine, including presentation, examination, and investigations, acute upper GI bleeding, acute gastroenteritis, jaundice, complications of cirrhosis, acute liver failure, infections and the liver, complications in liver transplant recipients, pregnancy and the liver ...
Professor Kevin Moore +2 more
+4 more sources
Nanomedicines in gastroenterology and hepatology
Nature Reviews Gastroenterology & Hepatology, 2015Nanoscale systems are currently under investigation for multiple different diagnostic and therapeutic applications. These systems can be used to identify pathologically changed tissues or to selectively deliver drugs to these sites; both applications have an extremely high potential to ameliorate therapeutic outcomes for patients.
openaire +2 more sources
Gastroenterology and Hepatology
JAMA: The Journal of the American Medical Association, 1986Although endoscopy is an established and useful diagnostic tool, its emergency use in acute gastrointestinal tract bleeding has not reduced mortality. 1 However, high-risk groups whose management and ultimate outcome might be influenced favorably by early endoscopy have been identified: patients with visible vessels or fresh blood in ulcer craters (who
openaire +1 more source
Gastroenterology and Hepatology
Gastroenterology and hepatology encompass the prevention, diagnosis, and management of disorders affecting the gastrointestinal tract, liver, biliary system, and pancreas. These conditions account for a substantial proportion of global morbidity and healthcare utilization, ranging from common functional gastrointestinal disorders to complex ...openaire +2 more sources
Gastroenterology and Hepatology
JAMA: The Journal of the American Medical Association, 1987Dramatic advances have occurred in many areas of gastroenterology. For example, new drugs are being developed for the treatment of Crohn's disease and ulcerative colitis. One of the most important is salicylazosulfapyridine, which has been used for years to treat acute attacks of ulcerative colitis and to minimize the risk of relapse.
openaire +1 more source

